AstraZeneca Pharma India net profit declines 55 per cent to Rs 12 crores in Q2

AstraZeneca Pharma India recently reported a 54.65 per cent decline in its net profit to Rs 11.94 crores for the quarter ended 30th September, 2021.

The company had posted a net profit of Rs 26.33 crores for the corresponding period of the previous financial year, it said in a filing to the BSE.

Its revenue from operations during July-September 2021 stood at Rs 197.70 crores. It was Rs 209.47 crores for the same period a year ago, it added.